SABCS 2018: Phase III KATHERINE clinical trial crossed early reporting boundary and met its primary endpoint
Substituting trastuzumab emtansine (T-DM1, Kadcyla) for adjuvant trastuzumab (Herceptin) in patients who had residual disease…
Browsing: herceptin
Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug
An antibody that binds simultaneously to two distinct regions of the HER2 receptor to block…
Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer
For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be…
Two drugs prevent heart problems in breast cancer patients
Data released today from a large multi-center study provides a view into the effectiveness of…
Drug-resistant cancers kill millions – here’s how we’re tackling them
By Joe Sutton, Edinburgh Napier University Cancer treatment is often highly effective at first, yet patients’ tumours…
Shorter herceptin breast cancer treatment may produce better results
Breast cancer patients who receive the drug herceptin for nine weeks as part of their…
Immunotherapy: Training the body to fight cancer
Balveen Kaur, The Ohio State University and Pravin Kaumaya, The Ohio State University The human…
Study links two genes to breast cancer survival
Testing for the activity of two genes could pick out women who are at increased…
Researchers restore drug sensitivity in breast cancer tumours
A team of cancer researchers has uncovered one way certain tumours resist vital medication. In the…
European Medicines Agency issues alert after vials of Herceptin stolen from Italian hospitals
The European Medicines Agency (EMA) has been informed that vials of Herceptin (trastuzumab), thought to…